GlassScriptPhysician profile
Emil L Gurshumov
NPI 1942529367
$2,552.48
in general payments reported to CMS, 2019-2025
14 companies · $563 in 2025
The $563 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $236 · 2021: $356 · 2022: $560 · 2023: $380 · 2024: $223 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,166.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $763.66 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $676.04 | 2023-2025 | Gemtesa |
| Urovant Sciences INC | $317.90 | 2021-2022 | |
| Femselect INC. | $237.81 | 2025 | Enplace |
| Amgen INC. | $176.02 | 2019-2025 | Evenity |
| Axonics, INC. | $127.29 | 2023-2024 | Bulkamid |
| Caldera Medical, INC | $101.91 | 2025 | |
| Intuitive Surgical, INC. | $29.00 | 2022 | |
| Pfizer INC. | $25.35 | 2019-2020 | |
| Convatec INC. | $24.71 | 2021 | |
| Therapeuticsmd, INC. | $23.44 | 2020 | |
| 180 Medical, INC. | $21.55 | 2021 | |
| Boston Scientific Corporation | $16.90 | 2020 | |
| Avanos Medical | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emil Gurshumov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.